- Home
- TNGX vs SWBI Comparison
TNGX vs SWBI Comparison
Compare TNGX & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- SWBI
- Stock Information
- Founded
- TNGX 2014
- SWBI 1852
- Country
- TNGX United States
- SWBI United States
- Employees
- TNGX N/A
- SWBI N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- SWBI Ordnance And Accessories
- Sector
- TNGX Health Care
- SWBI Industrials
- Exchange
- TNGX Nasdaq
- SWBI Nasdaq
- Market Cap
- TNGX 413.6M
- SWBI 451.0M
- IPO Year
- TNGX N/A
- SWBI N/A
- Fundamental
- Price
- TNGX $2.85
- SWBI $10.33
- Analyst Decision
- TNGX Strong Buy
- SWBI Hold
- Analyst Count
- TNGX 8
- SWBI 2
- Target Price
- TNGX $13.14
- SWBI $13.00
- AVG Volume (30 Days)
- TNGX 1.2M
- SWBI 535.6K
- Earning Date
- TNGX 11-06-2024
- SWBI 03-06-2025
- Dividend Yield
- TNGX N/A
- SWBI 5.07%
- EPS Growth
- TNGX N/A
- SWBI 23.33
- EPS
- TNGX N/A
- SWBI 0.79
- Revenue
- TNGX $43,383,000.00
- SWBI $514,645,000.00
- Revenue This Year
- TNGX $27.73
- SWBI N/A
- Revenue Next Year
- TNGX N/A
- SWBI $6.77
- P/E Ratio
- TNGX N/A
- SWBI $13.11
- Revenue Growth
- TNGX 15.67
- SWBI 0.32
- 52 Week Low
- TNGX $2.59
- SWBI $9.68
- 52 Week High
- TNGX $13.01
- SWBI $18.05
- Technical
- Relative Strength Index (RSI)
- TNGX 41.79
- SWBI 43.36
- Support Level
- TNGX $2.60
- SWBI $10.07
- Resistance Level
- TNGX $3.65
- SWBI $10.33
- Average True Range (ATR)
- TNGX 0.25
- SWBI 0.26
- MACD
- TNGX 0.01
- SWBI 0.15
- Stochastic Oscillator
- TNGX 24.88
- SWBI 85.06
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.